Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Ilin

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Nanomaterials (Basel, Switzerland)|January 21, 2022
Quantum-Chemical Quasi-Docking for Molecular Dynamics CalculationsAlexey Sulimov, Danil Kutov, Ivan Ilin, et al.
Molecules (Basel, Switzerland)|May 14, 2022
Novel Inhibitors of 2'-<i>O</i>-Methyltransferase of the SARS-CoV-2 CoronavirusAlexey Sulimov, Danil Kutov, Ivan Ilin, et al.
Molecules (Basel, Switzerland)|September 9, 2022
New Chemicals Suppressing SARS-CoV-2 Replication in Cell CultureAlexey Sulimov, Ivan Ilin, Danil Kutov, et al.
Molecules (Basel, Switzerland)|February 25, 2022
New Blood Coagulation Factor XIIa Inhibitors: Molecular Modeling, Synthesis, and Experimental ConfirmationAnna Tashchilova, Nadezhda Podoplelova, Alexey Sulimov, et al.
Molecular Informatics|November 3, 2022
Experimentally Validated Novel Factor XIIa Inhibitors Identified by Docking and Quantum Chemical Post-processingIvan Ilin, Nadezhda Podoplelova, Alexey Sulimov, et al.
Journal of Molecular Graphics & Modelling|March 27, 2019
New factor Xa inhibitors based on 1,2,3,4-tetrahydroquinoline developed by molecular modellingIvan Ilin, Elena Lipets, Alexey Sulimov, et al.
Molecules (Basel, Switzerland)|April 25, 2020
Synthesis, Docking, and In Vitro Anticoagulant Activity Assay of Hybrid Derivatives of Pyrrolo[3,2,1-<i>ij</i>]Quinolin-2(1<i>H</i>)-one as New Inhibitors of Factor Xa and Factor XIaNadezhda Novichikhina, Ivan Ilin, Anna Tashchilova, et al.
Scientific Data|March 3, 2026
Molecular LEGION: incalculably large coverage of chemical space around the NLRP3 targetBogdan Zagribelnyy, Vladimir Aladinskiy, Nikita Bondarev, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Nanomaterials (Basel, Switzerland)|January 21, 2022
Quantum-Chemical Quasi-Docking for Molecular Dynamics CalculationsAlexey Sulimov, Danil Kutov, Ivan Ilin, et al.
Molecules (Basel, Switzerland)|May 14, 2022
Novel Inhibitors of 2'-<i>O</i>-Methyltransferase of the SARS-CoV-2 CoronavirusAlexey Sulimov, Danil Kutov, Ivan Ilin, et al.
Molecules (Basel, Switzerland)|September 9, 2022
New Chemicals Suppressing SARS-CoV-2 Replication in Cell CultureAlexey Sulimov, Ivan Ilin, Danil Kutov, et al.
Molecules (Basel, Switzerland)|February 25, 2022
New Blood Coagulation Factor XIIa Inhibitors: Molecular Modeling, Synthesis, and Experimental ConfirmationAnna Tashchilova, Nadezhda Podoplelova, Alexey Sulimov, et al.
Molecular Informatics|November 3, 2022
Experimentally Validated Novel Factor XIIa Inhibitors Identified by Docking and Quantum Chemical Post-processingIvan Ilin, Nadezhda Podoplelova, Alexey Sulimov, et al.
Journal of Molecular Graphics & Modelling|March 27, 2019
New factor Xa inhibitors based on 1,2,3,4-tetrahydroquinoline developed by molecular modellingIvan Ilin, Elena Lipets, Alexey Sulimov, et al.
Molecules (Basel, Switzerland)|April 25, 2020
Synthesis, Docking, and In Vitro Anticoagulant Activity Assay of Hybrid Derivatives of Pyrrolo[3,2,1-<i>ij</i>]Quinolin-2(1<i>H</i>)-one as New Inhibitors of Factor Xa and Factor XIaNadezhda Novichikhina, Ivan Ilin, Anna Tashchilova, et al.
Scientific Data|March 3, 2026
Molecular LEGION: incalculably large coverage of chemical space around the NLRP3 targetBogdan Zagribelnyy, Vladimir Aladinskiy, Nikita Bondarev, et al.
Pageof 1